Relevium Medical
Description: Relevium Medical develops peptide-based therapeutics for chronic conditions, starting with Hydrobloc-01 for knee osteoarthritis, entering trials in 2022.
Country: Ireland
Based in: Galway
Founded: 2019
Funding Stage: Pre-Seed
Tags: ['Alternative Medicine', 'Pharmaceutical', 'Medical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
